Drugs: From Discovery to Approval

other_versions_link

The new edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manuf...

Full description

Bibliographic Details
Main Author: Rick NG
Format: Printed Book
Published: Hoboken, New Jersey Wiley-Blackwell 2009
Edition:2nd ed.
Subjects:
Drug development. Technology, Pharmaceutical. Chemistry, Pharmaceutical. Clinical Trials as Topic > methods.
LEADER 02523nam a2200193Ia 4500
999 |c 28755  |d 28755 
020 |a 9780470195109 
082 |a 615.19 RIC-D 
100 |a  Rick NG 
245 |a Drugs: From Discovery to Approval 
250 |a 2nd ed. 
260 |b Wiley-Blackwell  |c  2009  |a Hoboken, New Jersey 
300 |a  xiii, 466 pages : illustrations ; 24 cm 
505 |a  Drug discovery : targets and receptors -- Drug discovery : small molecule drugs -- Drug discovery : large molecule drugs -- Drug development and preclinical studies -- Clinical trial -- Regulatory authorities -- Regulatory applications -- Good manufacturing practice : regulatory requirements -- Good manufacturing practice : drug manufacturing -- Future perspectives. 
520 |a The new edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs.This second edition features many key enhancements, including Key Points, Chapter Summary, and Review Questions in each chapter, Answers to Review Questions provided in a book-end appendix, and one or two carefully selected \\\\\\\mini\\\\\\\ case studies in each chapter.Richly illustrated throughout with over ninety figures and tables, this important book also includes helpful listings of current FDA and European guidelines and a special section on regulatory authority and processes in China. It is an indispensable resource for pharmaceutical industry and academic researchers, pharmaceutical managers and executives, healthcare clinicians, policymakers, regulators, and lobbyists with an interest in drug development. It is also an excellent textbook for students in pharmacy, science, and medicine courses. 
650 |a Drug development. Technology, Pharmaceutical. Chemistry, Pharmaceutical. Clinical Trials as Topic --methods. 
942 |c BK 
952 |0 0  |1 0  |4 0  |6 615_190000000000000_RICD  |7 0  |9 31477  |a DCB  |b DCB  |e MBC-0695/13  |l 1  |o 615.19 RIC-D  |p DCB2355  |r 2018-01-04  |s 2017-05-18  |w 2019-07-19  |y BK 
952 |0 0  |1 0  |4 0  |6 615_190000000000000_RICD  |7 0  |9 31478  |a DCB  |b DCB  |d 2016-01-01  |l 2  |o 615.19 RIC-D  |p DCB2354  |r 2019-05-14  |s 2019-05-14  |w 2019-07-19  |y BK 

Similar Items